MB
MPM BioImpact Portfolio holdings
AUM
$577M
This Quarter Return
+37.1%
1 Year Return
+8.33%
3 Year Return
+241.63%
5 Year Return
+127.38%
10 Year Return
–
AUM
$622M
AUM Growth
+$622M
(+46%)
Cap. Flow
+$83.7M
Cap. Flow
% of AUM
13.46%
Top 10 Holdings %
Top 10 Hldgs %
55.49%
Holding
44
New
12
Increased
14
Reduced
4
Closed
6
Top Buys
| 1 |
Zentalis Pharmaceuticals
ZNTL
|
$23.9M |
| 2 |
Sutro Biopharma
STRO
|
$23.1M |
| 3 |
Natera
NTRA
|
$15.8M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
$11.5M |
| 5 |
89bio
ETNB
|
$11.3M |
Top Sells
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$16.9M |
| 2 |
Iovance Biotherapeutics
IOVA
|
$16.1M |
| 3 |
CBAY
Cymabay Therapeutics
CBAY
|
$14.4M |
| 4 |
Viking Therapeutics
VKTX
|
$14.4M |
| 5 |
Structure Therapeutics
GPCR
|
$9.4M |
Sector Composition
| 1 | Healthcare | 100% |
